ponencia 08 pharmacist_uk_steele_j
TRANSCRIPT
![Page 1: Ponencia 08 pharmacist_uk_steele_j](https://reader033.vdocuments.site/reader033/viewer/2022052903/5577e248d8b42a7b7b8b4cc7/html5/thumbnails/1.jpg)
Influencing Prescribing in Primary Care in the NHS
Janice SteelePrimary Care Pharmacist
![Page 2: Ponencia 08 pharmacist_uk_steele_j](https://reader033.vdocuments.site/reader033/viewer/2022052903/5577e248d8b42a7b7b8b4cc7/html5/thumbnails/2.jpg)
Croydon Primary Care Trust
� 150 PCTs in England
� Population of Croydon 340,000� 65 GP surgeries
� 66 community pharmacies� Primary care drugs budget £45million
![Page 3: Ponencia 08 pharmacist_uk_steele_j](https://reader033.vdocuments.site/reader033/viewer/2022052903/5577e248d8b42a7b7b8b4cc7/html5/thumbnails/3.jpg)
Local Health Issues
� Inequalities gap in life expectancy
� High black and minority ethnic group population
� 3 biggest killers – Circulatory disease– Cancer– Respiratory disease
![Page 4: Ponencia 08 pharmacist_uk_steele_j](https://reader033.vdocuments.site/reader033/viewer/2022052903/5577e248d8b42a7b7b8b4cc7/html5/thumbnails/4.jpg)
History
� Prescribing advice pilot 1998� Team expanded 1999� Dual quality and cost effective prescribing
agenda� IT developments� Relationship building� Infrastructure� National Initiatives NICE , NPSA, QuOF
![Page 5: Ponencia 08 pharmacist_uk_steele_j](https://reader033.vdocuments.site/reader033/viewer/2022052903/5577e248d8b42a7b7b8b4cc7/html5/thumbnails/5.jpg)
Key factors for success
� Strategic co-ordination
� Tailored implementation� Clinical engagement at all levels
� Communication� Well trained workforce
![Page 6: Ponencia 08 pharmacist_uk_steele_j](https://reader033.vdocuments.site/reader033/viewer/2022052903/5577e248d8b42a7b7b8b4cc7/html5/thumbnails/6.jpg)
Strategic co-ordination
� Area prescribing committee– Clinical representatives from acute hospitals– Chaired by public health consultant– Members of the public– Links to networks and sectors
� Primary Care Prescribing Group– Agree practical implementation of annual
workplan
![Page 7: Ponencia 08 pharmacist_uk_steele_j](https://reader033.vdocuments.site/reader033/viewer/2022052903/5577e248d8b42a7b7b8b4cc7/html5/thumbnails/7.jpg)
Tailored implementation
� 9 pharmacists provide tailored support� Annual visits - present data, discuss issues,
agree priorities to work on +/- support� Quarterly data provided to monitor progress� Comprehensive information packs developed
for each therapeutic area� Query answer service on individual patient
medicine management issues
![Page 8: Ponencia 08 pharmacist_uk_steele_j](https://reader033.vdocuments.site/reader033/viewer/2022052903/5577e248d8b42a7b7b8b4cc7/html5/thumbnails/8.jpg)
Clinical Engagement
� Prescribing lead� Clinical opinion leaders� Peer pressure/ use of comparative graphs� Incentive scheme� Consistent use of the evidence base� Long term issues not just quick financial wins� Supportive� Look at prescribing processes as well as drugs
![Page 9: Ponencia 08 pharmacist_uk_steele_j](https://reader033.vdocuments.site/reader033/viewer/2022052903/5577e248d8b42a7b7b8b4cc7/html5/thumbnails/9.jpg)
Communication
� Newsletters
� Reinforcement at practice meetings� Teaching sessions
� Website� Prescribing support tools
� Patient information material
![Page 10: Ponencia 08 pharmacist_uk_steele_j](https://reader033.vdocuments.site/reader033/viewer/2022052903/5577e248d8b42a7b7b8b4cc7/html5/thumbnails/10.jpg)
Example- Statin switch programme
� Horizon scanning� Extensive review of the evidence� Explicit about risks as well as financial gains� Agreement by key committees� Presented to group of opinion leaders-consensus� Prepared support pack� Anticipated common questions/concerns � Patient information leaflet� Looked at clinical outcomes as well as financial
![Page 11: Ponencia 08 pharmacist_uk_steele_j](https://reader033.vdocuments.site/reader033/viewer/2022052903/5577e248d8b42a7b7b8b4cc7/html5/thumbnails/11.jpg)
Statins continued
� Intervention form- standard approach� Communication with community pharmacists� Contact number for queries� Replicated pharmaceutical industry approach� Trained workforce� Piloted material� Incentive scheme� Targeted outliers � Messages reinforced regularly- newsletters , visits
![Page 12: Ponencia 08 pharmacist_uk_steele_j](https://reader033.vdocuments.site/reader033/viewer/2022052903/5577e248d8b42a7b7b8b4cc7/html5/thumbnails/12.jpg)
![Page 13: Ponencia 08 pharmacist_uk_steele_j](https://reader033.vdocuments.site/reader033/viewer/2022052903/5577e248d8b42a7b7b8b4cc7/html5/thumbnails/13.jpg)
![Page 14: Ponencia 08 pharmacist_uk_steele_j](https://reader033.vdocuments.site/reader033/viewer/2022052903/5577e248d8b42a7b7b8b4cc7/html5/thumbnails/14.jpg)
![Page 15: Ponencia 08 pharmacist_uk_steele_j](https://reader033.vdocuments.site/reader033/viewer/2022052903/5577e248d8b42a7b7b8b4cc7/html5/thumbnails/15.jpg)
![Page 16: Ponencia 08 pharmacist_uk_steele_j](https://reader033.vdocuments.site/reader033/viewer/2022052903/5577e248d8b42a7b7b8b4cc7/html5/thumbnails/16.jpg)
![Page 17: Ponencia 08 pharmacist_uk_steele_j](https://reader033.vdocuments.site/reader033/viewer/2022052903/5577e248d8b42a7b7b8b4cc7/html5/thumbnails/17.jpg)
![Page 18: Ponencia 08 pharmacist_uk_steele_j](https://reader033.vdocuments.site/reader033/viewer/2022052903/5577e248d8b42a7b7b8b4cc7/html5/thumbnails/18.jpg)
![Page 19: Ponencia 08 pharmacist_uk_steele_j](https://reader033.vdocuments.site/reader033/viewer/2022052903/5577e248d8b42a7b7b8b4cc7/html5/thumbnails/19.jpg)
![Page 20: Ponencia 08 pharmacist_uk_steele_j](https://reader033.vdocuments.site/reader033/viewer/2022052903/5577e248d8b42a7b7b8b4cc7/html5/thumbnails/20.jpg)
![Page 21: Ponencia 08 pharmacist_uk_steele_j](https://reader033.vdocuments.site/reader033/viewer/2022052903/5577e248d8b42a7b7b8b4cc7/html5/thumbnails/21.jpg)
![Page 22: Ponencia 08 pharmacist_uk_steele_j](https://reader033.vdocuments.site/reader033/viewer/2022052903/5577e248d8b42a7b7b8b4cc7/html5/thumbnails/22.jpg)
Current Issues
� Structural reform of the NHS
� GP commissioning consortia� New initiatives + old ones to maintain
– Waste– Reducing patient admissions– Improving patient compliance– QIPP quality, innovation, PRODUCTIVITY,
prevention